Miracles
for Kids operates the Molly’s Kids Grant
Program at Children’s Hospital of Orange County
(CHOC) to provide financial assistance to
pediatric oncology patients and their families
and/or caregivers.
The Grant Program is an application-driven
program with
the goal of assisting families who are
struggling to make ends meet as a result of
their child’s illness. Applicants are screened
by their CHOC Pediatric Oncology Social Services
representative and if approved, submit an
application for assistance directly to Miracles
for Kids. There is very little red tape
associated with the program, and as are funds to
provided directly to the families, Miracles for
Kids is able to assist those in need very
quickly.
To learn more about the Molly’s Kids Grant
Program or to donate, please contact us at
info@miraclesforkids.org. |
Miracles for Kids is a proud supporter of
the Pediatric Cancer Research Foundation.
PCRF was established in 1982 as a local
resource to improve the care quality of life
and survival rate of children with malignant
diseases. Since that time, PRCF has raised
over $20 million dollars, with over 80% of
every dollar raised going directly to
research.
PCRF funds grants
for research in:
●
Stem cell transplantation
● Stem cell biology
● Molecular oncology
● Molecular and cellular genetics
PCRF currently
funds research grants to the
following institutions:
●
Children’s Hospital of
Orange County
●
Children’s Hospital
of Los Angeles
●
Mattel Children’s Hospital
at UCLA
●
University of California,
Los Angeles
●
The Marrow Foundation
●
City of Hope National
Medical Center
●
UCLA School of Medicine
To learn more about PCRF, visit their
website at
www.pcrf-kids.org.
|
As
part of its commitment to find a cure for
pediatric cancer, Miracles for Kids has
partnered with the Pediatric Cancer Research
Foundation (PCRF) to fund an ongoing
clinical trial at the
City of Hope National Medical Center in
Southern California.
The clinical trial, in its second year of
operation, will allow a person, for the
first time, to receive genetically modified
T cells, a type of immune cell, in
combination with chemotherapy to target
their lymphoma. A major step forward in the
fight against pediatric cancer, the T-cell
trial helps establish the fact that T cells
can be manipulated in the laboratory to
target tumors resistant to conventional
therapy.
To read a summary on the current status of
the clinical trial being conducted at City
of Hope,
click here. |
